• Profile
Close

Preoperative methylprednisolone increases plasma Pentraxin PTX3 early after total knee arthroplasty: A randomized, double-blind, placebo-controlled trial

Clinical and Experimental Immunology Oct 21, 2017

Lindberg-Larsen V, et al. - In this study, researchers assessed early postoperative changes in pentraxin-3 (PTX3) and other complement marker in total knee arthroplasty (TKA) patients who received methylprednisolone (MP) preoperatively. Findings demonstrated that early after TKA, increased circulating PTX3 and reduced general inflammatory response (CRP) were evident as consequences of preoperative administration of MP 125 mg, however, no influence was seen on other complement markers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay